Skip to content
AnalystLens
Back to RPRXIncome Statement

Royalty Pharma Revenue 2018-2026 | RPRX

Annual FY2018–FY2025 · quarterly through Q2 FY2026

Latest annual · FY2025

$2.38B

+5.1%YoY vs FY2024Source: 10-KFY2025

From $1.79B in FY2018 to $2.38B in FY2025: 1.3× in 7 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$631M+11.0%$674M+16.5%Not reportedNot reported
FY25$568M0.0%$579M+7.7%$609M+7.9%$622M+4.8%
FY24$568M−17.0%$537M−0.2%$565M+5.3%$594M−0.4%
FY23$684M+21.7%$538M+0.4%$536M−6.5%$596M+5.4%
FY22$562M−1.9%$536M−3.4%$573M−2.1%$566M−1.7%
Share25%24%25%26%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionStable
CAGR

+2.3%

FY2020
$2.12B
FY2025
$2.38B

5 years selected · on the chart

Revenue History

Year-over-year comparison from 10-K annual reports

  1. $2.38B
YoY changeLargest recent move+17.0%in FY20Latest +5.1%

Revenue, period by period

PeriodValueChangeSource
FY2025$2.38B+5.1%10-K
FY2024$2.26B−3.9%10-K
FY2023$2.35B+5.2%10-K
FY2022$2.24B−2.3%10-K
FY2021$2.29B+7.9%10-K
FY2020$2.12B+17.0%10-K
FY2019$1.81B+1.1%10-K
FY2018$1.79B—10-K

What is revenue?

Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

What is Royalty Pharma's current revenue?

Royalty Pharma (RPRX) annual revenue for 2025 was $2.38B, a 5.06% increase from 2024. Royalty Pharma revenue for the quarter ending June 30, 2026 was $674.1M.

What was Royalty Pharma's revenue in 2024?

Royalty Pharma annual revenue for 2024 was $2.26B, a 3.86% decline from 2023.

What was Royalty Pharma's revenue in 2023?

Royalty Pharma annual revenue for 2023 was $2.35B, a 5.24% increase from 2022.

What is Royalty Pharma's 5-year revenue CAGR?

Royalty Pharma revenue grew at a compound annual growth rate (CAGR) of 2.30% from FY2020 to FY2025, going from $2.12B to $2.38B over 5 years.

Company
Royalty Pharma
Ticker
RPRX
Sector
Healthcare
Industry
Pharmaceutical Preparations